We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Flu Study, on Hold, Yields New Vaccine Technology

News   Sep 07, 2015

 
Flu Study, on Hold, Yields New Vaccine Technology
 
 
 

RELATED ARTICLES

World’s First Genetically Enhanced Human Vascular Cells

News

Scientists have generated the world's first genetically enhanced human vascular cells by targeting a single longevity gene, FOXO3.

READ MORE

Embryonic Chick Study Reveals How Cells are Recruited to Form Hindgut

News

New study uses live imaging to understand a critical step in early embryonic development—how genes and molecules control forces to orchestrate the emergence of form in the developing embryo.

READ MORE

‘Shortcut’ Transforms Terpene Biosynthesis in E. Coli

News

Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE